Interacting Drugs |
Influenza virus vaccine (live attenuated) vs Immunosuppressants |
Security Level |
 |
Mechanism |
Immunosuppressants: May enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live). |
Management |
Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants. Exceptions: AzaTHIOprine; Beclomethasone; Beclomethasone (Oral Inhalation); Betamethasone; Budesonide; Budesonide (Systemic, Oral Inhalation); Corticotropin; Cortisone; Cytarabine (Liposomal); Dexamethasone; Dexamethasone (Systemic); Fludrocortisone; Fluticasone; Fluticasone (Oral Inhalation); Hydrocortisone; Hydrocortisone (Systemic); Hydroxychloroquine; Leflunomide; Mercaptopurine; Methotrexate; MethylPREDNISolone; Mometasone; PrednisoLONE; PrednisoLONE (Systemic); PredniSONE; Triamcinolone; Triamcinolone (Systemic). |
Influenza virus vaccine (live attenuated) vs Immunosuppressants
Post Review about Influenza virus vaccine (live attenuated) vs Immunosuppressants Click here to cancel reply.
Other Interactions of Influenza virus vaccine (live attenuated)
Other Interactions of Immunosuppressants
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.